KRAS and pancreatic adenocarcinoma: For the Ras proteins, KRAS/HRAS/NRAS all harbor highly recurrent mutations for residues p.G12/G13 that affect large fractions of pancreatic adenocarcinoma (PAAD), COAD, READ, lung adenocarcinoma (LUAD), and UCEC.